Literature DB >> 16538411

Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases.

Fredericke H van Duijnhoven1, Maarten C Jansen, Jan M C Junggeburt, Richard van Hillegersberg, Arjen M Rijken, Frits van Coevorden, Joost R van der Sijp, Thomas M van Gulik, Gerrit D Slooter, Joost M Klaase, Hein Putter, Rob A E M Tollenaar.   

Abstract

BACKGROUND: The prognosis of patients with colorectal cancer is poor, especially when there is distant metastatic disease. Local ablation of tumor by radiofrequency ablation (RFA) has emerged as a safe and effective new treatment modality, but its long-term efficacy may be hindered by renewed local tumor growth at the site of RFA. The objectives of this study were to identify risk factors for local RFA failure and to define exclusion criteria for RFA treatment of colorectal liver metastases.
METHODS: A total of 199 lesions in 87 patients were ablated with RFA. Factors influencing local failure rates were identified and compared with data from the literature.
RESULTS: The local failure rate was 47.2%, and the average time to local disease progression was 6.5 months. Factors that significantly correlated with increased failure rates were metachronous occurrence of liver metastases, large mean lesion size, and central tumor location.
CONCLUSIONS: Because accurate electrode placement is pivotal in achieving adequate tumor necrosis, RFA should not be performed percutaneously when electrode placement is impaired. We suggest that lesions >5 cm and lesions located near great vessels or adjacent organs should be treated with open RFA, thus allowing vascular inflow occlusion and complete mobilization of the liver. Lesions that are difficult to reach by electrodes should be approached by an open procedure.

Entities:  

Mesh:

Year:  2006        PMID: 16538411     DOI: 10.1245/ASO.2006.08.014

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  39 in total

1.  Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation.

Authors:  Astrid Gasselhuber; Matthew R Dreher; Ayele Negussie; Bradford J Wood; Frank Rattay; Dieter Haemmerich
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

2.  Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention.

Authors:  A A J M Van Tilborg; M R Meijerink; C Sietses; J H T M Van Waesberghe; M O Mackintosh; S Meijer; C Van Kuijk; P Van Den Tol
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

3.  Microwave ablation in a hepatic porcine model: correlation of CT and histopathologic findings.

Authors:  Michael M Awad; Lara Devgan; Ihab R Kamel; Michael Torbensen; Michael A Choti
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

4.  Percutaneous ablation of post-surgical solitary early recurrence of colorectal liver metastases is an effective "test-of-time" approach.

Authors:  Luca Vigano; Jacopo Galvanin; Dario Poretti; Daniele Del Fabbro; Damiano Gentile; Vittorio Pedicini; Luigi Solbiati; Guido Torzilli
Journal:  Updates Surg       Date:  2021-04-12

5.  Laparoscopic image-based navigation for microwave ablation of liver tumors-A multi-center study.

Authors:  Pascale Tinguely; Matteo Fusaglia; Jacob Freedman; Vanessa Banz; Stefan Weber; Daniel Candinas; Henrik Nilsson
Journal:  Surg Endosc       Date:  2017-03-24       Impact factor: 4.584

6.  [Metastases of colorectal carcinoma].

Authors:  S Clasen; H Rempp; P L Pereira
Journal:  Radiologe       Date:  2008-11       Impact factor: 0.635

7.  Incidence and treatment of local site recurrences following RFA of colorectal liver metastases.

Authors:  Karin Nielsen; Aukje A J M van Tilborg; Martijn R Meijerink; Matessa O Macintosh; Babs M Zonderhuis; Elly S M de Lange; Emile F I Comans; Sybren Meijer; M Petrousjka van den Tol
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

Review 8.  Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases.

Authors:  Sherif Raafat Zikry Abdel-Misih; Carl R Schmidt; Paul Mark Bloomston
Journal:  World J Surg Oncol       Date:  2009-09-29       Impact factor: 2.754

9.  Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study.

Authors:  F Jeroen Vogelaar; Wilma E Mesker; Arjen M Rijken; Gaby W van Pelt; Antonia M van Leeuwen; Hans J Tanke; Rob A Tollenaar; Gerrit J Liefers
Journal:  BMC Cancer       Date:  2010-04-20       Impact factor: 4.430

10.  Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases.

Authors:  K Homayounfar; T Liersch; G Schuetze; M Niessner; A Goralczyk; J Meller; C Langer; B M Ghadimi; H Becker; T Lorf
Journal:  Int J Colorectal Dis       Date:  2008-12-16       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.